USA - NYSE:ABC - US03073E1055 - Common Stock
The current stock price of ABC is 179.98 USD. In the past month the price decreased by -4.82%. In the past year, price increased by 21.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.22 | 104.74B | ||
| COR | CENCORA INC | 22.64 | 70.17B | ||
| CAH | CARDINAL HEALTH INC | 23.05 | 48.79B | ||
| HSIC | HENRY SCHEIN INC | 14.82 | 8.66B | ||
| AHCO | ADAPTHEALTH CORP | 28.72 | 1.24B | ||
| OMI | OWENS & MINOR INC | 2.17 | 216.27M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 59.01M |
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. The company is headquartered in Conshohocken, Pennsylvania and currently employs 39,000 full-time employees. The firm's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The firm also focuses on specialty services and a global platform of pharma manufacturer services capabilities.
AMERISOURCEBERGEN CORP
1 West First Avenue
Conshohocken PENNSYLVANIA 19428 US
CEO: Steven H. Collis
Employees: 39000
Phone: 16107277000.0
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. The company is headquartered in Conshohocken, Pennsylvania and currently employs 39,000 full-time employees. The firm's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The firm also focuses on specialty services and a global platform of pharma manufacturer services capabilities.
The current stock price of ABC is 179.98 USD. The price decreased by -0.23% in the last trading session.
AMERISOURCEBERGEN CORP (ABC) has a dividend yield of 1.08%. The yearly dividend amount is currently 1.59.
ABC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for AMERISOURCEBERGEN CORP (ABC) is 15.34. This is based on the reported non-GAAP earnings per share of 11.73 and the current share price of 179.98 USD.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ABC.
AMERISOURCEBERGEN CORP (ABC) will report earnings on 2023-11-01, before the market open.
ChartMill assigns a technical rating of 4 / 10 to ABC. When comparing the yearly performance of all stocks, ABC is one of the better performing stocks in the market, outperforming 85.78% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ABC. ABC has an average financial health and profitability rating.
Over the last trailing twelve months ABC reported a non-GAAP Earnings per Share(EPS) of 11.73. The EPS increased by 8.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.66% | ||
| ROA | 2.76% | ||
| ROE | 246.27% | ||
| Debt/Equity | 6.06 |
20 analysts have analysed ABC and the average price target is 213.76 USD. This implies a price increase of 18.77% is expected in the next year compared to the current price of 179.98.
For the next year, analysts expect an EPS growth of 9.02% and a revenue growth 8.52% for ABC